Penn Davis Mcfarland Inc. Sells 26 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Penn Davis Mcfarland Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,462 shares of the healthcare conglomerate’s stock after selling 26 shares during the period. UnitedHealth Group makes up about 3.6% of Penn Davis Mcfarland Inc.’s portfolio, making the stock its 10th largest position. Penn Davis Mcfarland Inc.’s holdings in UnitedHealth Group were worth $32,428,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Swedbank AB bought a new position in shares of UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after acquiring an additional 1,196,758 shares during the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $480,903,000. Dimensional Fund Advisors LP boosted its holdings in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Finally, Baillie Gifford & Co. lifted its position in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after buying an additional 821,050 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, October 16th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Robert W. Baird upped their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Stephens lowered their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $615.58.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $569.61 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50-day moving average price is $584.42 and its two-hundred day moving average price is $534.68. The stock has a market cap of $525.99 billion, a P/E ratio of 37.11, a PEG ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.